Clinical Trial Update: Impact of Ranolazine on Coronary Microcirculatory Resistance [NA]

View source ↗

Summary

A completed clinical trial evaluating the impact of ranolazine on coronary microcirculatory resistance; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Microcirculation Disorders
• Ischemia

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University of New Mexico | Conditions: Coronary Microcirculation, Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2023-12-26